Psychiatry MMC | A peer-reviewed journal providing evidence-based information to practicing clinicians

Psychiatry MMC

Sponsors

Issue Archives

Use of Benzodiazepines in the Treatment of Anxiety

September 2008

by Elisa Cascade and Amir H. Kalali, MD

Ms. Cascade is Vice President, Quintiles Inc./iGuard, Falls Church, Virginia; and Dr. Kalali is Vice President, Global Therapeutic Group Leader CNS, Quintiles Inc., San Diego, California, and Professor of Psychiatry, University of California, San Diego.

Read the rest of this article »

Posted in 09-2008 (September 2008), Original Research, Trend Watch | No Comments »

Short-acting versus Long-acting Medications for the Treatment of ADHD

August 2008

by Elisa Cascade; Amir H. Kalali, MD; and Richard H. Weisler, MD

Ms. Cascade is Vice President, Quintiles Inc./iGuard, Falls Church, Virginia; Dr. Kalali is Vice President, Global Therapeutic Group Leader CNS, Quintiles Inc., San Diego, California, and Professor of Psychiatry, University of California, San Diego; and Dr. Weisler is an Adjunct Professor of Psychiatry at the University of North Carolina, Chapel Hill and Adjunct Associate Professor of Psychiatry at Duke University, Durham, North Carolina.

Read the rest of this article »

Posted in 08-2008 (August 2008), Trend Watch | No Comments »

Use of Atypical Antipsychotics in the Elderly

July 2008

by Elisa Cascade; Amir H. Kalali, MD; and Jeffrey L. Cummings, MD

Ms. Cascade is Vice President, Quintiles Inc./iGuard, Falls Church, Virginia; Dr. Kalali is Vice President, Global Therapeutic Group Leader CNS, Quintiles Inc., San Diego, California, and Professor of Psychiatry, University of California, San Diego; and Dr. Cummings is from the Departments of Neurology and Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine at UCLA, Los Angeles, California.

Read the rest of this article »

Posted in 07-2008 (July 2008), Trend Watch | No Comments »

Varying Uses of Anticonvulsant Medications

June 2008

by Elisa Cascade; Amir H. Kalali, MD; and Richard H. Weisler, MD

Ms. Cascade is Vice President, Quintiles Inc./iGuard, Falls Church, Virginia; Dr. Kalali is Vice President, Global Therapeutic Group Leader CNS, Quintiles Inc., San Diego, California, and Professor of Psychiatry, University of California, San Diego; and Dr. Weisler is an Adjunct Professor of Psychiatry at the University of North Carolina, Chapel Hill and Adjunct Associate Professor of Psychiatry at Duke University, Durham, North Carolina.

Read the rest of this article »

Posted in 06-2008 (June 2008), Trend Watch | No Comments »

Current Management of Schizophrenia: Antipsychotic Monotherapy versus Combination Therapy

May 2008

by Elisa F. Cascade; Amir H. Kalali, MD; Peter F. Buckley, MD

Ms. Cascade is Vice President, Quintiles Inc./iGuard, Falls Church, Virginia; Dr. Kalali is Vice President, Global Therapeutic Group Leader CNS, Quintiles Inc., San Diego, California, and Professor of Psychiatry, University of California, San Diego; and Dr. Buckley is Professor and Chairman, Department of Psychiatry,
Medical College of Georgia, Augusta, Georgia.

Read the rest of this article »

Posted in 05-2008 (May 2008), Trend Watch | No Comments »

Generic Penetration of the SSRI Market

April 2008

by Elisa F. Cascade and Amir H. Kalali, MD

Ms. Cascade is Vice President, Strategic Research and Safety, Quintiles Inc., Falls Church, Virginia; and Dr. Kalali is Vice President, Global Therapeutic Group Leader CNS, Quintiles Inc., San Diego, California, and Professor of Psychiatry, University of California, San Diego.

Read the rest of this article »

Posted in 04-2008 (April 2008), Trend Watch | No Comments »

Treatment of Fibromyalgia

March 2008

by Elisa F. Cascade; Amir H. Kalali, MD; Nikhil D. Nihalani, MD; and Thomas L. Schwartz, MD

Read the rest of this article »

Posted in 03-2008 March 2008, Trend Watch | No Comments »

Treatment of Autistic Children

February 2008

by Elisa F. Cascade; Amir H. Kalali, MD; and David Feifel, MD, PhD

Ms. Cascade is Vice President, Strategic Research and Safety, Quintiles Inc., Falls Church, Virginia; Dr. Kalali is Vice President, Global Therapeutic Group Leader CNS, Quintiles Inc., San Diego, California, and Professor of Psychiatry, University of California, San Diego; and Dr. Feifel is Associate Professor In Residence, Department of Psychiatry; Director, Neuropsychiatry and Behavioral Medicine Program; Director, UCSD Adult ADHD Program, University of California, San Diego Medical Center, San Diego, California.

Read the rest of this article »

Posted in 02-2008 (February 2008), Trend Watch | No Comments »

Seasonality and the Changing Adult/Child Prescription Ratios in ADHD Therapy

January 2008

by Elisa Cascade; Amir H. Kalali, MD; Richard H. Weisler, MD; and Susan Lenderts

Ms. Cascade is Vice President, Strategic Research and Safety, Quintiles Inc., Falls Church, Virginia; Dr. Kalali is Vice President, Global Therapeutic Group Leader CNS, Quintiles Inc., San Diego, California, and Professor of Psychiatry, University of California, San Diego; Dr. Weisler is an Adjunct Professor of Psychiatry at the University of North Carolina, Chapel Hill and Adjunct Associate Professor of Psychiatry at Duke University, Durham, North Carolina; and Ms. Lenderts is with Quintiles, Inc.

Read the rest of this article »

Posted in 01-2008 (January 2008), Trend Watch | No Comments »

Use of Antidepressants: Expansion Beyond Depression and Anxiety

December 2007

by Elisa F. Cascade; Amir H. Kalali, MD; and Michael E. Thase, MD

Ms. Cascade is Vice President, Strategic Research and Safety, Quintiles Inc., Falls Church, Virginia; Dr. Kalali is Vice President, Global Therapeutic Group Leader CNS, Quintiles Inc., San Diego, California, and Professor of Psychiatry, University of California, San Diego; and Dr. Thase is Professor, Departments of Psychiatry, University of Pennsylvania School of Medicine, Philadelphia Veterans Affairs Medical Center, and University of Pittsburgh Medical Center.

Read the rest of this article »

Posted in 12-2007 (December 2007), Trend Watch | No Comments »

cheap viagra